Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Clearance for Schering-Plough's extended-release Claritin-D

Sep. 6, 1996

SKB claims NK3 antagonists for pulmonary disorders

Aug. 30, 1996

SKB reports on PDE IV inhibitor research

Aug. 30, 1996

Scirex to manage IND filing for Apanol

Aug. 30, 1996

Usherdex-4 and other dextrans covered under U.S. patent

Aug. 23, 1996

Forest's Infasurf earns approvable status

Aug. 23, 1996

FR-173657: Fujisawa's bradykinin B2 antagonist

Aug. 23, 1996

PAF antagonist Y-24180 enters phase III

Aug. 23, 1996

Proventil HFA given FDA approval

Aug. 23, 1996

Hoechst Marion Roussel launches Allegra on U.S. market

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...